Panitumumab nonlinear population PK
A two-compartment population PK model coupling panitumumab distribution to parallel linear and saturable Michaelis–Menten elimination.
- Therapeutic
- Panitumumab
- Target
- Not reported
- Disease
- Cancer therapy with EGFR-targeted panitumumab
Biological model
A two-compartment population PK model coupling panitumumab distribution to parallel linear and saturable Michaelis–Menten elimination.
Intervention
Panitumumab
Biological focus
PopPK
Context
Cancer therapy with EGFR-targeted panitumumab
Model details
A two-compartment population PK model coupling panitumumab distribution to parallel linear and saturable Michaelis–Menten elimination.
Modeled states
- auc mg day lmg*day/L
Modeled dynamic state for auc mg day l.
- central mgmg
Modeled dynamic state for central mg.
- elapsed dayday
Modeled dynamic state for elapsed day.
- peripheral mgmg
Modeled dynamic state for peripheral mg.
Key readouts
- Central panitumumab concentrationunknown
Model-derived readout for central panitumumab concentration.
- Peripheral panitumumab concentrationunknown
Model-derived readout for peripheral panitumumab concentration.
- Linear eliminationunknown
Model-derived readout for linear elimination.
- Saturable eliminationunknown
Model-derived readout for saturable elimination.
- Cumulative panitumumab exposuremg*day/L
Model-derived readout for cumulative panitumumab exposure.
Explore this model
Choose a starting point to view its result. Adjust key model inputs when you want to explore a different outcome.
Typical FFCD0904 3 mg/kg every 2 weeks with AUC
How do linear and saturable elimination jointly shape panitumumab concentration and exposure? Explore this intervention regimen through Central panitumumab concentration, Peripheral panitumumab concentration, Linear elimination, Saturable elimination, Cumulative panitumumab exposure. This is a mechanistic product exploration, not a paper-result reproduction.
Questions to explore
- How do linear and saturable elimination jointly shape panitumumab concentration and exposure?
Starting result
This result reflects the starting settings. Run your changes to update it.
Model inputs
Five scientist-facing controls at most.
Compare a parameter
How does one model input change the response?
How do linear and saturable elimination jointly shape panitumumab concentration and exposure?
cl l day
Model parameter controlling cl l day.
Exploratory range around the default value.
5 evenly spaced values in L/day. Other model inputs and the simulation window stay fixed.
Interpret with care
- Interpret trajectories as deterministic model behavior, not as a patient-specific prediction or dosing recommendation.
- Paper-result and exact-anchor checks remain in the private validation lane and are not part of this public scenario.
Review the server-confirmed fixed price before starting the comparison.
Comparative response
End-of-window response across the selected parameter values.
Choose an exploratory range around the default, review the fixed price, and run the comparison.
